Board

In “Procedures for Election of Directors and Supervisors,” the company clearly stipulates the principle of diversification of the board of directors, strengthens corporate governance, and promotes the sound development of the board’s composition and structure. Directors are elected and nominated through a candidate nomination system. After the board of directors passes the resolution, they are submitted to the shareholders’ meeting for selection. To formulate an appropriate diversification policy based on its own operations, business model, and development requirements, it should include, but not be limited to, the two major aspects of the standard listed below:

(i) Fundamental qualities and values: gender, age, nationality, and culture, etc.

(ii) Professional knowledge and abilities: professional background (such as law, accounting, industry, finance, marketing, or technology), professional skills, industrial experience, business management, an international perspective, management and decision-making skills, etc.

Board Member
Title	Name	Education / Experience	Current Position
Chairman	Chen, Jen	．Ph.D. in Chemistry, University of Rochester, USA ．Novartis Program Host ．Genelabs, Vice Chairman of Asia Sales ．QPS-Qualitix Clinical Research Co., Chairman ．Bio Taiwan Committee (BTC), Executive Yuan, Committee Member	．Genovate Biotechnology Co., Chairman and CSO ．Quest Pharmaceutical Services Taiwan Co., Corporate Representative (Director) ．Genovate Biotechnology (Cayman) Co., Corporate Representative (Director) ．Unipharma Co., Chairman and CSO ．Reber Genetics Co., Corporate Representative (Director) ．NaviFUS Corporation, corporate representative (Chairman) and CSO ．Genovate NaviFus (Australia)Pty., Corporate Representative (Director) ．Savior Lifetec Corporation, Corporate Representative (Director)
Director	Chen, Hsiu-Hui	．Ph.D. Department of Agricultural Chemistry, NTU ．Head of CEO Office and Planning and Examination Office, Research Fellow of R&D Division, Development Center for Biotechnology ．Research Fellow, Yi Cheng Biotech ．Postdoctoral Fellow, Academia Sinica	．Associate Executive Officer, Development Center for Biotechnology ．EirGenix Inc., Corporate Representative (Director),
Director	Huang, Chi-Ying	．Ph.D. Department of Biochemistry, Biophysics, Iowa State University ．Director, PharmaEngine Inc. ．Associate Research Fellow, National Health Research Institutes ．Postdoctoral Fellow, Dept. of Chemical & Systems Biology, Stanford University	．Distinguished Professor and Director, Department of Pharmacy, National Yang Ming Chiao Tung University ．Associate Director, Department of Pharmacy, National Yang Ming Chiao Tung University ．Chong Hin Loon Memorial Cancer and Biotherapy Research Center, National Yang Ming Chiao Tung University, Director ．Jointly-Appointed Professor, Department of Biochemistry, Kaohsiung Medical University ．Intech Biopharm Co., Corporate Representative (Director)
Director	Chu, Chia-Chen	．Master’s Degree, Science in Health Policy and Management, Harvard University ．Ministry of Health and Welfare, Associate Researcher ．Genovate Biotechnology Co., Director of International Affairs ．Genovate Biotechnology Co., New Drug Development Department, Vice President	．Genovate Biotechnology Co., General Manager ．Uni Pharma Co., Corporate Representative (Director) ．NaviFUS Corporation, Corporate Representative (Director) ．Genovate NaviFus Inc., Corporate Representative (Director) ．Genovate NaviFus (Australia) Pty. Corporate Representative (Director)
Independent Director	Lee, Shih-Jen	．Ph.D. in Chemistry, University of South Carolina ．Easywell Biomedicals, Inc., Chairman ．Haoli Biotechnology Management Consulting Co., Managing Director ．Heyu Management Consulting Co., Investment Director ．Silver Biotech Management, Inc. Managing Director ．China Development Industrial Bank Senior Associate of Investment Department	．TAHO Pharmaceuticals , Chairman ．Sunko Ink Co., Independent Director ．Transwell Biotech Co., Director ．Industrial Technology Investment Co., Director ．Taimed Biologics Inc., Independent Director ．OBI Pharma Inc., Independent Director ．Amphastar Pharmaceuticals, Inc., Director
Independent Director	Liu, Ke-Yi	．Ph.D. in Accounting, Xiamen University ．Master of Accounting, University of Illinois ．Bachelor of Finance and Taxation, National Chengchi University	．BDO Taiwan Joint Venture Accountant ．Taiwan Cooperative Financial Holding Co., Independent Director
Independent Director	Chang, Chin-Ming	．Ph.D. in Pharmacy, University of Texas at Austin ．Graduated in Department of Pharmacy, National Taiwan University ．Senior Executive in Pharmaceuticals, Processing and R&D, Allergan Inc. ．Senior Research Fellow, Eli Lilly & Company	．TaiMed Biologics, CEO ．Biotheravision Inc., Director ．Oukejian Biomedical Technology Co., Director
Independent Director	Su, Lai-Shou	．M.B.A. of University of North Texas, U.S.A. ．Executive Secretary of National Development Fund ．Board Director of Oversea-Chinese Banking Corporation ．Board Director of HanTech Venture Capital Corporation ．Board Director of Taiwan Aerospace Corporation ．Supervisor of Kaohsiung Rapid Transit Corporation ．Supervisor of Powerchip Semiconductor Corporation ．Supervisor of Mirle Automation Corporation	．ScinoPharm Taiwan Co., Independent Director ．Locus Cell Co., Corporate Representative (Director) ．TOP Pharma & Bio-Tech Co., Director ．CY Biotech Co., Director